BML Investment Partners, L.P. 13D and 13G filings for Athira Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 10:21 am Purchase | 2024-12-31 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 3,027,163 7.800% | 542,718 (+21.84%) | Filing |
| 2025-02-14 09:59 am Unchanged | 2024-12-31 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 2,484,445 6.500% | 0 (Unchanged) | Filing |
| 2024-11-07 1:15 pm Purchase | 2024-11-01 | 13G | Athira Pharma, Inc. ATHA | BML Investment Partners, L.P. | 2,484,445 6.500% | 2,484,445 (New Position) | Filing |